Cargando…

RECIST criteria: our experience in daily practice

Detalles Bibliográficos
Autores principales:	De Luca, S, Carrera, C, Vañek, E Casalini, Tolkachier, L, Alarcon, L, Eyheremendy, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601850/ http://dx.doi.org/10.1186/1470-7330-15-S1-P31

Ejemplares similares

Reporting oncoimaging in the appropriate oncology setting
por: De Luca, S, et al.
Publicado: (2015)

MR and PET/CT imaging in diagnosis of large pelvic masses
por: De Luca, S, et al.
Publicado: (2015)

Thoracic pseudotumours: a pictorial essay
por: De Luca, S, et al.
Publicado: (2015)

Utility of dual time point 18 FDG PET-CT
por: De Luca, SE, et al.
Publicado: (2014)

Acute presentation of oncologic disease
por: De Luca, SE, et al.
Publicado: (2014)

Hepatocellularcarcinoma: current imaging techniques
por: De Luca, S, et al.
Publicado: (2015)

Role of high resolution MR in assessment of cervical uterine carcinoma: staging, treatment planning and correlation with histopathology findings
por: Grana, MF, et al.
Publicado: (2015)

Response assessment in daily practice: RECIST and its modifications
por: Sohaib, Aslam
Publicado: (2014)

Value of DWI volumetry for assessment of complete rectal cancer response after CRT
por: Nazar, M, et al.
Publicado: (2015)

Value of DWI- ADC and FUSION T2-DWI in the management of oncological patients
por: Nazar, M, et al.
Publicado: (2015)

What the radiologist needs to know about restaging of rectal carcinoma after chemoradiation therapy
por: Nazar, ME, et al.
Publicado: (2014)

HIV patients in the ICU: our experience
por: Nunes Velloso, V, et al.
Publicado: (2012)

Imaging tumour response: beyond RECIST
por: Koh, Dow-Mu
Publicado: (2014)

2-year outcome of juvenile idiopathic arthritis in current daily practice: what can we tell our patients?
por: Anink, Janneke, et al.
Publicado: (2011)

Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
por: Lin, Chien-Ju, et al.
Publicado: (2015)

Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria
por: Zhou, Meng, et al.
Publicado: (2021)

Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST
por: Goldmacher, Gregory V., et al.
Publicado: (2020)

Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602
por: Sato, Yozo, et al.
Publicado: (2013)

Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
por: Costelloe, Colleen M., et al.
Publicado: (2010)

Usefulness of peanut and hazelnut molecular components for the diagnosis of nut allergy. Our experience in clinical practice
por: Rotiroti, Giuseppina, et al.
Publicado: (2011)

Food-induced anaphylaxis: our experience
por: Di Paolo, Camilla, et al.
Publicado: (2011)

T1 mapping in daily CMR practice
por: Nadjiri, Jonathan, et al.
Publicado: (2014)

Prolonged sedation in ARDS patients with inhaled anesthetics: our experience
por: Redaelli, S, et al.
Publicado: (2013)

Our experience of anti-interleukin 1 therapy
por: Gulez, N, et al.
Publicado: (2015)

RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline
por: van Persijn van Meerten, Els L., et al.
Publicado: (2009)

ECMO in nonintubated patients as a bridge to lung transplant: our experience
por: Chierichetti, M, et al.
Publicado: (2012)

ICU and TIPS, our experience in a community hospital in spain
por: Leal Micharet, AM, et al.
Publicado: (2015)

RECIST rules
por: Sohaib, Aslam
Publicado: (2012)

Patients with spina bifida and bladder cancer. Our experience
por: Pagès, Esther, et al.
Publicado: (2010)

Safety of treatment with biologics for psoriasis in daily practice: 5-year data
por: Van Lümig, PPM, et al.
Publicado: (2010)

WHO, RECIST, and immune-related response criteria: is it time to revisit pembrolizumab results?
por: Ades, Felipe, et al.
Publicado: (2015)

Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review
por: Min, Seon Jeong, et al.
Publicado: (2016)

Patterns of response in metastatic NSCLC during PD‐1 or PD‐L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteria
por: Liang, Hongge, et al.
Publicado: (2020)

Conscious sedation in non comatose patients submitted to intra - arterial thrombolysis: our experience
por: Valzani, Y, et al.
Publicado: (2015)

Standard operating procedures in postresuscitation care: facilitated realisation therapeutic measures in daily practice
por: Busch, HJ, et al.
Publicado: (2008)

Improving team work during bedside rounds: using daily goals and best practices
por: Adamson, M, et al.
Publicado: (2010)

Prenatal diagnosis of Tay-Sachs disease: our institutional experience
por: Sheth, Jayesh, et al.
Publicado: (2014)

Surgical tactics in treatment of traumatic raptures of the diaphragm: our experience
por: Mkrtchyan, M, et al.
Publicado: (2013)

Use of extracorporeal membrane oxygenation in Croatian lung transplantation programme. Our initial experience
por: Pavlisa, G, et al.
Publicado: (2013)

Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments: a pooled analysis
por: Kim, Hong Deok, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dj4p88odda4qqg46v7afet0sm8